NLRP3 end products IL-18 and caspase-1 are associated with AD pathogenesis, while interleukin-1β (IL-1β) is an established disruptor of the BBB, linking it to microbial brain access (discussed in detail in “Senescence and Inflammasomes” section). Here, IL18 is linked to Alzheimer disease.